Related Experiment Video

Updated: Jul 7, 2026

Cycloheximide Chase Analysis of Protein Degradation in Saccharomyces cerevisiae
09:05

Cycloheximide Chase Analysis of Protein Degradation in Saccharomyces cerevisiae

Published on: April 18, 2016

Drug-induced apoptosis in yeast

B Almeida1, A Silva, A Mesquita

  • 1Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Campus de Gualtar, Braga, Portugal.

Biochimica Et Biophysica Acta
|February 7, 2008
PubMed

Insights

Yeasts serve as a valuable model for studying programmed cell death (PCD) pathways, aiding in the development of novel anticancer and antifungal drugs by examining drug-induced apoptosis.

Area of Science:

  • * Molecular Biology and Pharmacology
  • * Cellular Biology and Drug Discovery

Background:

  • * Drug development is a critical research area focused on combating diseases like cancer and infections.
  • * Programmed cell death (PCD) modulation is a key mechanism in designing effective anticancer and antifungal drugs.
  • * Yeasts offer a conserved cellular machinery for studying PCD pathways relevant to higher eukaryotes.

Purpose of the Study:

  • * To explore the utility of yeast as a model organism for studying drug-induced apoptosis.
  • * To investigate the mechanisms of drug action on PCD pathways in yeast.
  • * To assess the potential of yeast-based models for developing targeted anticancer and antifungal therapies.

Main Methods:

  • * Review of existing literature on drug-induced apoptosis in yeast.
  • * Analysis of conserved PCD pathways between yeast and mammalian cells.
  • * Examination of reactive oxygen species (ROS) generation and mitochondrial function alterations.

Main Results:

  • * Anticancer drugs induce apoptosis in yeast via ROS generation and altered mitochondrial functions, similar to mammalian cells.
  • * Yeast models demonstrate conserved mechanisms of drug-induced apoptosis.
  • * Fungal-specific apoptotic regulators can be targeted for antifungal drug development.

Conclusions:

  • * Yeast is a powerful model for screening and developing PCD-directed drugs.
  • * Yeast models can help overcome cellular specificity issues in anticancer drug design.
  • * Targeting fungal-specific apoptotic pathways in yeast can lead to effective antifungal drugs with minimal impact on human cells.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Temporal Quantification of MAPK Induced Expression in Single Yeast Cells07:59

Temporal Quantification of MAPK Induced Expression in Single Yeast Cells

Published on: October 4, 2013

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Yeast Signaling01:28

Yeast Signaling

Yeasts are single-celled organisms, but unlike bacteria, they are eukaryotes (cells with a nucleus). Cell signaling in yeast is similar to signaling in other eukaryotic cells. A ligand, such as a protein or a small molecule released from a yeast cell, attaches to a receptor on the cell surface. The binding stimulates second-messenger kinases to activate or inactivate transcription factors that further regulate gene expression. Many of the yeast intracellular signaling cascades have similar...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...